Craneware plc
08 February 2008
Craneware plc
('Craneware' or the 'Company')
NOTICE OF RESULTS
8 February 2008 - Craneware plc, (AIM: CRW) a leader in revenue cycle management
software solutions for the US healthcare market, will be reporting its interim
results for the six months ended 31 December 2007 on Tuesday 26th February 2008.
The management team will be hosting an analyst briefing on the day at 11:15 at
the offices of ICIS, 3rd Floor, Aldermary House, 10 -15 Queen Street, London,
EC4N 1TX. Analysts who wish to attend should contact Mike Smith at ICIS on +44
(0) 20 7651 8688 or email Mike.Smith@icisnet.com to register.
For further information, please contact:
Craneware plc KBC Peel Hunt ICIS
+44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688
Keith Neilson, CEO Oliver Scott Tom Moriarty
Sandy McDougall, CFO Deon Veldtman Caroline Evans-Jones
About Craneware
Founded in 1999, Craneware has headquarters in Livingston, Scotland, with
offices in Florida, Arizona and Kansas, employing approximately 100 staff. The
Company's flagship product, Chargemaster Toolkit(R) ('CMT'), assists US
healthcare providers in reducing billing errors, ensuring the timely and
accurate submission of claims and managing compliance risk. More information
about Craneware plc and its services can be found on-line at the Company's
corporate website, www.craneware.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.